Author

Enrico Patrucco

University of TurinORCID 0000-0001-8060-5058Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:imaging· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Chiara AmbrogioiD· 2 shared Alice Di BernardoiD· 1 shared Alice PassoniiD· 1 shared Amelia LOCATELLIiD· 1 shared Andrea Olarte-San JuaniD· 1 shared Barbara MairiD· 1 shared CHRISTIAN ZANIRATOiD· 1 shared Claudio MedanaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Chiara AmbrogioORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintJul 28, 2026

An integrated biomaterials-centred approach of the ageing thymic microenvironment reveals design principles for regenerative biomaterials

Alice Di Bernardo, CHRISTIAN ZANIRATO, Francesco Briatico Vangosa…·Lorenzo Sardelli

This paper analyzes age-related changes in bovine thymus using multimodal techniques to identify mechanical, compositional, and spatial alterations that inform the design of regenerative biomaterials.

DOI 10.64898/2026.07.27.740917

chicken / avianimaging

𝕏 PostBluesky

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedMar 12, 2025

Pharmacological SOS1 inhibitor BI-3406 demonstrates in vivo anti-tumor activity comparable to SOS1 genetic ablation in KRAS mutant tumors

Fernando C. Baltanás, Maximilian Kramer‐Drauberg, Rósula García‐Navas…·Eugenio Santos

This study shows that the SOS1 inhibitor BI-3406 effectively reduces tumor growth in KRAS mutant cancers, similar to genetic SOS1 ablation, with comparable efficacy to another KRAS inhibitor.

16 citationstop 5%

mouseproteomics

𝕏 PostBluesky